Shiga toxin 2-specific but not shiga toxin 1-specific human monoclonal antibody protects piglets challenged with enterohemorrhagic escherichia coli producing shiga toxin 1 and shiga toxin 2

Journal of Infectious Diseases

Volumn 201, Issue 7, 2010, Pages 1081-1083

  Jeong, Kwang Il ^a   Tzipori, Saul ^a   Sheoran, Abhineet S ^a  

^a TUFTS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 5A4; MONOCLONAL ANTIBODY 5C12; UNCLASSIFIED DRUG; VEROTOXIN 1; VEROTOXIN 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL STRAIN; CONTROLLED STUDY; DRUG EFFICACY; ENTEROHEMORRHAGIC ESCHERICHIA COLI; ESCHERICHIA COLI INFECTION; INFECTION PREVENTION; NONHUMAN; PIGLET; PRIORITY JOURNAL; SHIGA TOXIN PRODUCING ESCHERICHIA COLI;

ANIMALS; ANTIBODIES, BACTERIAL; ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; ENTEROHEMORRHAGIC ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; HUMANS; SHIGA TOXIN 1; SHIGA TOXIN 2; SWINE;

EID: 77749343715     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/651198     Document Type: Article

References (11)

1. Milfbrd DV, Taylor CM, Guttridge B, Hall SM, Rowe B, Kleanthous H. Haemolytic uraemie syndromes in the British Isles 1985-1988: association with verocytotoxin producing Escherichia coli. I. Clinical and epidemiological aspects. Arch Dis Child 1990;65:716-721.
2. Friedrich AW, Bielaszewska M, Zhang WL, et al. Escherichia coli harboring Shiga toxin 2 gene variants: frequency and association with clinical symptoms. J Infect Dis 2002; 185:74-84.
3. Donohue-Rolfe A, Kondova I, Oswald S, Hutto D, Tzipori S. Esche-richia coli O157:H7 strains that express Shiga toxin (Stx) 2 alone are more neurotropic for gnotobiotic piglets than are isotypes producing only Stx1 or both Stx1 and Stx2. J. Infect Dis 2000; 181:1825-1829.
4. Sheoran AS, Chapman-Bonofiglio S, Harvey BR, et al. Human antibody against shiga toxin 2 administered to piglets after the onset of diarrhea due to Escherichia coli O157:H7 prevents fatal systemic complications. Infect Immun 2005;73:4607-4613.
5. Tzipori S, Sheoran A, Akiyoshi D, Donohue-Rolfe A, Trachtman H. Antibody therapy in the management of shiga toxin-induced hemolytic uremic syndrome. Clin Microbiol Rev 2004; 17:926-941.
6. Mukherjee J, Chios K, Fishwild D, et al. Human Stx2-specific monoclonal antibodies prevent systemic complications of Escherichia coli O157:H7 infection. Infect Immun 2002;70:612-619.
7. Mukherjee J, Chios K, Fishwild D, et al. Production and characterization of protective human antibodies against Shiga toxin 1. Infect Immun 2002;70:5896-5899.
8. Sheoran AS, Chapman S, Singh P, Donohue-Rolfe A, Tzipori S. Stx2-specific human monoclonal antibodies protect mice against lethal infection with Escherichia coli expressing Stx2 variants. Infect Immun 2003;71:3125-3130.
9. Akiyoshi DE, Rich CM, O'Sullivan-Murphy S, et al. Characterization of a human monoclonal antibody against Shiga toxin 2 expressed in Chinese hamster ovary cells. Infect Immun 2005;73:4054-4061. (Pubitemid 40923145)
10. Donohue-Rolfe A, Kondova I, Mukherjee J, Chios K, Hutto D, Tzipori S. Antibody-based protection of gnotobiotic piglets infected with Escherichia coli O157:H7 against systemic complications associated with Shiga toxin 2. Infect Immun 1999;67:3645-3648.
11. Gannon VP, Gyles CL, Wilcock BP. Effects of Escherichia coli Shigalike toxins (verotoxins) in pigs. Can J Vet Res 1989;53:306-312.